Clinical stage drug development company, Pharmaxis (ASX: PXS) is making a name for themselves in the oncology sector, with their…
Promising early study results released today by clinical stage drug development company Pharmaxis (ASX: PXS), should be a reason for…
Streamlining operations to focus on the most profitable side of their pharmaceuticals manufacturing business, Pharmaxis (ASX: PXS) has shored up…
In biotech circles, tackling a rare and difficult disease with few patients does not necessarily equate to targeting an unprofitable…
One of the world’s most respected surgeons in the field of burns and trauma recovery will lead world-first clinical trials…